Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis

被引:13
|
作者
Gander-Bui, Hang Thi Thuy [1 ,2 ]
Schlaurofli, Joeurolle [1 ]
Baumgartner, Johanna [1 ,2 ]
Walthert, Sabrina [1 ]
Genitsch, Vera [3 ]
van Geest, Geert [4 ]
Galvan, Jose A. [3 ]
Cardozo, Carmen [3 ]
Martinez, Cristina Graham [3 ]
Grans, Mona [5 ]
Muth, Sabine [5 ]
Bruggmann, Remy [4 ]
Probst, Hans Christian [5 ]
Gabay, Cem [6 ]
Freigang, Stefan [1 ]
机构
[1] Univ Bern, Inst Tissue Med & Pathol, Div Expt Pathol, CH-3008 Bern, Switzerland
[2] Univ Bern, Grad Sch Cellular & Biomed Sci, CH-3012 Bern, Switzerland
[3] Univ Bern, Inst Tissue Med & Pathol, CH-3008 Bern, Switzerland
[4] Univ Bern, Interfac Bioinformat Unit, CH-3012 Bern, Switzerland
[5] Univ Med Ctr Mainz, Inst Immunol, D-55131 Mainz, Germany
[6] Univ Hosp Geneva, Dept Med, Div Rheumatol, CH-1211 Geneva, Switzerland
基金
瑞士国家科学基金会;
关键词
HOST-DEFENSE; NLRP3; INFLAMMASOME; DENDRITIC CELLS; IMMUNITY; INNATE; RECOGNITION; INTERFERONS; HOMEOSTASIS; INFECTIONS; DEFICIENCY;
D O I
10.1016/j.immuni.2023.06.023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invasive fungal infections are associated with high mortality rates, and the lack of efficient treatment options emphasizes an urgency to identify underlying disease mechanisms. We report that disseminated Candida albicans infection is facilitated by interleukin-1 receptor antagonist (IL-1Ra) secreted from macrophages in two temporally and spatially distinct waves. Splenic CD169+ macrophages release IL-1Ra into the bloodstream, impeding early neutrophil recruitment. IL-1Ra secreted by monocyte-derived tissue macrophages further impairs pathogen containment. Therapeutic IL-1Ra neutralization restored the functional competence of neutrophils, corrected maladapted hyper-inflammation, and eradicated the otherwise lethal infection. Conversely, augmentation of macrophage-secreted IL-1Ra by type I interferon severely aggravated disease mortality. Our study uncovers how a fundamental immunoregulatory mechanism mediates the high disease susceptibility to invasive candidiasis. Furthermore, interferon-stimulated IL-1Ra secretion may exacerbate fungal dissemination in human patients with secondary candidemia. Macrophage-secreted IL-1Ra should be considered as an additional biomarker and potential therapeutic target in severe systemic candidiasis.
引用
收藏
页码:1743 / +
页数:28
相关论文
共 50 条
  • [1] Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis
    Gander-Bui, H.
    Schafli, J.
    Baumgartner, J.
    Walthert, S.
    Genitsch, V.
    van Geest, G.
    Galvan, J. A.
    Cardozo, C.
    Martinez, C. G.
    Grans, M.
    Bruggmann, R.
    Probst, H. C.
    Gabay, C.
    Freigang, S.
    Muth, S.
    SWISS MEDICAL WEEKLY, 2023, 153 : 4S - 4S
  • [2] ROLE OF INTERLEUKIN-1 AND THE THERAPEUTIC POTENTIAL OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN SEPSIS
    FISHER, CJ
    OPAL, SM
    LOWRY, SF
    SADOFF, JC
    LABRECQUE, JF
    DONOVAN, HC
    LOOKABAUGH, JL
    LEMKE, J
    PRIBBLE, JP
    STROMATT, SC
    VIGERS, GP
    RUSSELL, DA
    THOMPSON, RC
    CIRCULATORY SHOCK, 1994, 44 (01) : 1 - 8
  • [3] Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension
    Bui, Christine B.
    Kolodziej, Magdalena
    Lamanna, Emma
    Elgass, Kirstin
    Sehgal, Arvind
    Rudloff, Ina
    Schwenke, Daryl O.
    Tsuchimochi, Hirotsugu
    Kroon, Maurice A. G. M.
    Cho, Steven X.
    Maksimenko, Anton
    Cholewa, Marian
    Berger, Philip J.
    Young, Morag J.
    Bourke, Jane E.
    Pearson, James T.
    Nold, Marcel F.
    Nold-Petry, Claudia A.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [4] INTERLEUKIN-1 RECEPTOR ANTAGONIST - EFFECTIVENESS AGAINST INTERLEUKIN-1 FEVER
    COCEANI, F
    LEES, J
    REDFORD, J
    BISHAI, I
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1992, 70 (12) : 1590 - 1596
  • [5] Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane
    Cauli, A
    Yanni, G
    Panayi, GS
    BRITISH JOURNAL OF RHEUMATOLOGY, 1997, 36 (09): : 935 - 940
  • [6] Steroids induce a disequilibrium of secreted interleukin-1 receptor antagonist and interleukin-1β synthesis by human neutrophils
    Langereis, J. D.
    Oudijk, E-J. D.
    Schweizer, R. C.
    Lammers, J-W. J.
    Koenderman, L.
    Ulfman, L. H.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) : 406 - 415
  • [7] MACROPHAGE DOWN-REGULATION BY INTERLEUKIN-1 RECEPTOR ANTAGONIST
    CONTI, P
    DEMPSEY, RA
    AMERICAN JOURNAL OF HEMATOLOGY, 1992, 39 (04) : 310 - 311
  • [8] Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration
    Meyer, Nuala J.
    Reilly, John P.
    Anderson, Brian J.
    Palakshappa, Jessica A.
    Jones, Tiffanie K.
    Dunn, Thomas G.
    Shashaty, Michael G. S.
    Feng, Rui
    Christie, Jason D.
    Opal, Steven M.
    CRITICAL CARE MEDICINE, 2018, 46 (01) : 21 - 28
  • [9] Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat
    Mulcahy, NJ
    Ross, J
    Rothwell, NJ
    Loddick, SA
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (03) : 471 - 476
  • [10] Interleukin-1 Receptor Antagonist Protects against Lipopolysaccharide Induced Diaphragm Weakness in Preterm Lambs
    Karisnan, Kanakeswary
    Bakker, Anthony J.
    Song, Yong
    Noble, Peter B.
    Pillow, J. Jane
    Pinniger, Gavin J.
    PLOS ONE, 2015, 10 (04):